{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:33:02Z","timestamp":1788496382367,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070154"],"award-info":[{"award-number":["82070154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7222056"],"award-info":[{"award-number":["7222056"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["2022-1-2091"],"award-info":[{"award-number":["2022-1-2091"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study reported height prediction and longitudinal growth changes in Chinese pediatric patients with acute myeloid leukemia (AML) during and after treatment and their associations with outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Changes in 88 children with AML in percentages according to the growth percentile curve for Chinese boys\/girls aged 2\u201318\/0\u20132 years for body mass index (BMI), height, and weight from the time of diagnosis to 2 years off therapy were evaluated. The outcomes of AML were compared among patients with different BMI levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The proportion of underweight children (weight\u2009&lt;\u20095th percentile) increased significantly from the initial diagnosis to the end of consolidation treatment. The proportion of patients with low BMI (BMI\u2009&lt;\u20095th percentile) was highest (23.08%) during the consolidation phase, and no children were underweight, but 20% were overweight (BMI\u2009&gt;\u200975th percentile) after 2 years of drug withdrawal. Unhealthy BMI at the initial diagnosis and during intensive chemotherapy leads to poorer outcomes. For height, all patients were in the range of genetic height predicted based on their parents\u2019 height at final follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Physicians should pay more attention to the changes in height and weight of children with AML at these crucial treatment stages and intervene in time.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-024-04740-z","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T15:01:59Z","timestamp":1714489319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Longitudinal changes in body mass index, height, and weight in children with acute myeloid leukemia"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaojia","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaole","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengli","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"issue":"10357","key":"4740_CR1","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S0140-6736(22)01541-0","volume":"400","author":"X Ni","year":"2022","unstructured":"Ni X, Li Z, Li X, et al. Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China: a cross-sectional study. Lancet. 2022;400(10357):1020\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(22)01541-0.","journal-title":"Lancet"},{"issue":"10","key":"4740_CR2","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/s41375-018-0071-7","volume":"32","author":"M Rasche","year":"2018","unstructured":"Rasche M, Zimmermann M, Borschel L, et al. Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012. Leukemia. 2018;32(10):2167\u201377. https:\/\/doi.org\/10.1038\/s41375-018-0071-7.","journal-title":"Leukemia"},{"issue":"27","key":"4740_CR3","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1200\/JCO.2015.62.8289","volume":"33","author":"CM Zwaan","year":"2015","unstructured":"Zwaan CM, Kolb EA, Reinhardt D, et al. Collaborative efforts driving Progress in Pediatric Acute myeloid leukemia. J Clin Oncol. 2015;33(27):2949\u201362. https:\/\/doi.org\/10.1200\/JCO.2015.62.8289.","journal-title":"J Clin Oncol"},{"issue":"3","key":"4740_CR4","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1002\/cam4.5188","volume":"12","author":"W Hu","year":"2023","unstructured":"Hu W, Cheung YT, Tang Y, et al. Association between body mass index at diagnosis and outcomes in Chinese children with newly diagnosed acute lymphoblastic leukemia. Cancer Med. 2023;12(3):2850\u201360. https:\/\/doi.org\/10.1002\/cam4.5188.","journal-title":"Cancer Med"},{"issue":"1","key":"4740_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/cncr.34529","volume":"129","author":"A Wadhwa","year":"2023","unstructured":"Wadhwa A, Chen Y, Hageman L, et al. Body mass index during maintenance therapy and relapse risk in children with acute lymphoblastic leukemia: a children\u2019s Oncology Group report. Cancer. 2023;129(1):151\u201360. https:\/\/doi.org\/10.1002\/cncr.34529.","journal-title":"Cancer"},{"issue":"9","key":"4740_CR6","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1182\/bloodadvances.2021006090","volume":"6","author":"M Iijima","year":"2022","unstructured":"Iijima M, Stall M, Wang L, et al. Changes in body mass index, weight, and height in children with acute myeloid leukemia and the associations with outcome. Blood Adv. 2022;6(9):2824\u201334. https:\/\/doi.org\/10.1182\/bloodadvances.2021006090.","journal-title":"Blood Adv"},{"issue":"18","key":"4740_CR7","doi-asserted-by":"publisher","first-page":"6825","DOI":"10.1002\/cam4.3334","volume":"9","author":"T Ghosh","year":"2020","unstructured":"Ghosh T, Richardson M, Gordon PM, Ryder JR, Spector LG, Turcotte LM. Body mass index associated with childhood and adolescent high-risk B-cell acute lymphoblastic leukemia risk: a children\u2019s Oncology Group report. Cancer Med. 2020;9(18):6825\u201335. https:\/\/doi.org\/10.1002\/cam4.3334.","journal-title":"Cancer Med"},{"issue":"9","key":"4740_CR8","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3324\/haematol.2011.056390","volume":"97","author":"BC Medeiros","year":"2012","unstructured":"Medeiros BC, Othus M, Estey EH, Fang M, Appelbaum FR. Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia. Haematologica. 2012;97(9):1401\u20134. https:\/\/doi.org\/10.3324\/haematol.2011.056390.","journal-title":"Haematologica"},{"key":"4740_CR9","doi-asserted-by":"publisher","first-page":"7048078","DOI":"10.1155\/2018\/7048078","volume":"2018","author":"AM Saenz","year":"2018","unstructured":"Saenz AM, Stapleton S, Hernandez RG, et al. Body Mass Index at Pediatric Leukemia Diagnosis and the risks of Relapse and Mortality: findings from a single Institution and Meta-analysis. J Obes. 2018;2018:7048078. https:\/\/doi.org\/10.1155\/2018\/7048078.","journal-title":"J Obes"},{"issue":"3","key":"4740_CR10","doi-asserted-by":"publisher","first-page":"e704","DOI":"10.1542\/peds.2013-3332","volume":"133","author":"FF Zhang","year":"2014","unstructured":"Zhang FF, Kelly MJ, Saltzman E, Must A, Roberts SB, Parsons SK. Obesity in pediatric ALL survivors: a meta-analysis. Pediatrics. 2014;133(3):e704\u201315. https:\/\/doi.org\/10.1542\/peds.2013-3332.","journal-title":"Pediatrics"},{"issue":"14","key":"4740_CR11","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1200\/JCO.2008.21.1953","volume":"27","author":"L Diller","year":"2009","unstructured":"Diller L, Chow EJ, Gurney JG, et al. Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol. 2009;27(14):2339\u201355. https:\/\/doi.org\/10.1200\/JCO.2008.21.1953.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4740_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jpeds.2012.12.037","volume":"163","author":"E Vandecruys","year":"2013","unstructured":"Vandecruys E, Dhooge C, Craen M, Benoit Y, De Schepper J. Longitudinal linear growth and final height is impaired in childhood acute lymphoblastic leukemia survivors after treatment without cranial irradiation. J Pediatr. 2013;163(1):268\u201373. https:\/\/doi.org\/10.1016\/j.jpeds.2012.12.037.","journal-title":"J Pediatr"},{"issue":"8583","key":"4740_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0140-6736(88)91246-9","volume":"1","author":"PE Clayton","year":"1988","unstructured":"Clayton PE, Shalet SM, Morris-Jones PH, Price DA. Growth in children treated for acute lymphoblastic leukaemia. Lancet. 1988;1(8583):460\u20132.","journal-title":"Lancet"},{"key":"4740_CR14","unstructured":"O\u2019Donnell MR, Abboud CN, Altman J et al. NCCN Clinical Practice guidelines Acute myeloid leukemia. J Natl Compr Canc Netw. 2012;10(8)."},{"issue":"5","key":"4740_CR15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1200\/JCO.1990.8.5.813","volume":"8","author":"BD Cheson","year":"1990","unstructured":"Cheson BD, Cassileth PA, Head DR, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol. 1990;8(5):813\u20139.","journal-title":"J Clin Oncol"},{"key":"4740_CR16","doi-asserted-by":"publisher","unstructured":"Li J, Gao J, Liu A, et al. Homoharringtonine-based induction regimen improved the Remission Rate and Survival Rate in Chinese Childhood AML: a Report from the CCLG-AML 2015 protocol study. J Clin Oncol. 2023;JCO2202836. https:\/\/doi.org\/10.1200\/JCO.22.02836.","DOI":"10.1200\/JCO.22.02836"},{"issue":"7","key":"4740_CR17","first-page":"6","volume":"47","author":"H li","year":"2009","unstructured":"li H, Ji C, Zong X, Zhang Y. Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Chin J Pediatr. 2009;47(7):6.","journal-title":"Chin J Pediatr"},{"issue":"7","key":"4740_CR18","first-page":"6","volume":"47","author":"H li","year":"2009","unstructured":"li H, Ji C, Zong X, Zhang Y. Body mass index growth curves for Chinese children and adolescents aged 0 to 18 years. Chin J Pediatr. 2009;47(7):6.","journal-title":"Chin J Pediatr"},{"issue":"3","key":"4740_CR19","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/archpedi.1997.02170400110025","volume":"151","author":"HH Pomerance","year":"1997","unstructured":"Pomerance HH. Nelson Textbook of Pediatrics. Arch Pediatr Adolesc Med. 1997;151(3):324.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"4740_CR20","first-page":"1125","volume":"286","author":"S Bahmanpour","year":"2013","unstructured":"Bahmanpour S. Guideline: updates on the management of severe acute malnutrition in infants and children. Organ WHJJoBC. 2013;286(2):1125\u201333.","journal-title":"Organ WHJJoBC"},{"issue":"244","key":"4740_CR21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1136\/adc.45.244.755","volume":"45","author":"JM Tanner","year":"1970","unstructured":"Tanner JM, Goldstein H, Whitehouse RH. Standards for children\u2019s height at ages 2\u20139 years allowing for heights of parents. Arch Dis Child Dec. 1970;45(244):755\u201362. https:\/\/doi.org\/10.1136\/adc.45.244.755.","journal-title":"Arch Dis Child Dec"},{"key":"4740_CR22","unstructured":"Zhang S. Chinese wrist bone age standard: China 05 and its application. 2015."},{"issue":"21","key":"4740_CR23","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1002\/cncr.31736","volume":"124","author":"EK Browne","year":"2018","unstructured":"Browne EK, Zhou Y, Chemaitilly W, et al. Changes in body mass index, height, and weight in children during and after therapy for acute lymphoblastic leukemia. Cancer. 2018;124(21):4248\u201359. https:\/\/doi.org\/10.1002\/cncr.31736.","journal-title":"Cancer"},{"issue":"7","key":"4740_CR24","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/pbc.24960","volume":"61","author":"FF Zhang","year":"2014","unstructured":"Zhang FF, Rodday AM, Kelly MJ, et al. Predictors of being overweight or obese in survivors of pediatric acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer. 2014;61(7):1263\u20139. https:\/\/doi.org\/10.1002\/pbc.24960.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"4740_CR25","doi-asserted-by":"publisher","first-page":"e28706","DOI":"10.1002\/pbc.28706","volume":"68","author":"A Meral G\u00fcnes","year":"2021","unstructured":"Meral G\u00fcnes A, Millot F, Kalwak K, et al. Features and outcome of chronic myeloid leukemia at very young age: data from the International Pediatric Chronic Myeloid Leukemia Registry. Pediatr Blood Cancer. 2021;68(1):e28706. https:\/\/doi.org\/10.1002\/pbc.28706.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"4740_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/MPH.0b013e318166247e","volume":"30","author":"R Dubowy","year":"2008","unstructured":"Dubowy R, Graham M, Hakami N, et al. Sequential oral hydroxyurea and intravenous cytosine arabinoside in refractory childhood acute leukemia: a pediatric oncology group phase 1 study. J Pediatr Hematol Oncol. 2008;30(5):353\u20137. https:\/\/doi.org\/10.1097\/MPH.0b013e318166247e.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"9","key":"4740_CR27","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1136\/archdischild-2016-311535.57","volume":"101","author":"F Aljebab","year":"2016","unstructured":"Aljebab F, Choonara I, Conroy S, LONG-COURSE ORAL, CORTICOSTEROID TOXICITY IN CHILDREN. Arch Dis Child. 2016;101(9):e2. https:\/\/doi.org\/10.1136\/archdischild-2016-311535.57.","journal-title":"Arch Dis Child"},{"issue":"6","key":"4740_CR28","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1007\/s00520-022-06910-0","volume":"30","author":"A Agarwal","year":"2022","unstructured":"Agarwal A, Kapoor G, Jain S, Malhotra P, Sharma A. Metabolic syndrome in childhood cancer survivors: delta BMI a risk factor in lower-middle-income countries. Support Care Cancer. 2022;30(6):5075\u201383. https:\/\/doi.org\/10.1007\/s00520-022-06910-0.","journal-title":"Support Care Cancer"},{"issue":"2","key":"4740_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1001\/jama.293.2.203","volume":"293","author":"BJ Lange","year":"2005","unstructured":"Lange BJ, Gerbing RB, Feusner J, et al. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA. 2005;293(2):203\u201311.","journal-title":"JAMA"},{"issue":"23","key":"4740_CR30","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1002\/cncr.27640","volume":"118","author":"H Inaba","year":"2012","unstructured":"Inaba H, Surprise HC, Pounds S, et al. Effect of body mass index on the outcome of children with acute myeloid leukemia. Cancer. 2012;118(23):5989\u201396. https:\/\/doi.org\/10.1002\/cncr.27640.","journal-title":"Cancer"},{"key":"4740_CR31","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.2147\/CMAR.S180724","volume":"11","author":"T Knight","year":"2019","unstructured":"Knight T, Edwards H, Taub JW, Ge Y. Evaluating venetoclax and its potential in treatment-na\u00efve acute myeloid leukemia. Cancer Manag Res. 2019;11:3197\u2013213. https:\/\/doi.org\/10.2147\/CMAR.S180724.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"4740_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","volume":"16","author":"RS Bhansali","year":"2023","unstructured":"Bhansali RS, Pratz KW, Lai C. Recent advances in targeted therapies in acute myeloid leukemia. J Hematol Oncol. 2023;16(1):29. https:\/\/doi.org\/10.1186\/s13045-023-01424-6.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"4740_CR33","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1038\/bcj.2015.110","volume":"6","author":"K Bochennek","year":"2016","unstructured":"Bochennek K, Hassler A, Perner C, et al. Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004. Blood Cancer J. 2016;6(1):e382. https:\/\/doi.org\/10.1038\/bcj.2015.110.","journal-title":"Blood Cancer J"},{"issue":"3","key":"4740_CR34","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/cncr.23581","volume":"113","author":"H Inaba","year":"2008","unstructured":"Inaba H, Fan Y, Pounds S, et al. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis. Cancer. 2008;113(3):522\u20139. https:\/\/doi.org\/10.1002\/cncr.23581.","journal-title":"Cancer"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04740-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-024-04740-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-024-04740-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T15:05:33Z","timestamp":1714489533000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-024-04740-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4740"],"URL":"https:\/\/doi.org\/10.1186\/s12887-024-04740-z","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]},"assertion":[{"value":"6 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study and its protocol was approved by the Medical Ethics Committee of Beijing Children\u2019s Hospital, Capital Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and statement"}},{"value":"was obtained from all patients or legal guardians in accordance with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"293"}}